# APIXABAN
> **NDA220446** · New Drug Application · Sponsor: LUPIN · Approved 2026-09-25
## Drug
- **FDA Application Number:** NDA220446
- **Application type:** New Drug Application
- **Brand name:** APIXABAN
- **Generic name:** Apixaban
- **Active ingredients:** APIXABAN
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LUPIN
- **First approval:** 2026-09-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220446)
---
*MORVS · CC0 1.0*